Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
about
Bone Regeneration from PLGA Micro-NanoparticlesDesign and optimization of PLGA-based diclofenac loaded nanoparticlesThermosensitive and mucoadhesive sol-gel composites of paclitaxel/dimethyl-β-cyclodextrin for buccal deliverySynthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid)Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery.Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imagingOnline monitoring of PLGA microparticles formation using Lasentec focused beam reflectance (FBRM) and particle video microscope (PVM).Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment.Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system.AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.Effects of spray-drying on w/o/w multiple emulsions prepared from a stearic acid matrixConjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug deliveryPractical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics.Aptamer-labeled PLGA nanoparticles for targeting cancer cells.The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study.Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges.Nanoparticles of biodegradable polymers for new-concept chemotherapy.Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes.Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.Highly porous drug-eluting structures: from wound dressings to stents and scaffolds for tissue regenerationA covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide deliverySynthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.Microemulsions as novel drug carriers: the formation, stability, applications and toxicity.Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.Cationic polybutyl cyanoacrylate nanoparticles for DNA deliveryPaclitaxel Nano-Delivery Systems: A Comprehensive Review.Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer TreatmentFormulation of anastrozole microparticles as biodegradable anticancer drug carriers.Increased localized delivery of piroxicam by cationic nanoparticles after intra-articular injection.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Docetaxel nanotechnology in anticancer therapy.Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.Nanomicellar carriers for targeted delivery of anticancer agents.Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.Brain-Derived Neurotrophic Factor Loaded PS80 PBCA Nanocarrier for In Vitro Neural Differentiation of Mouse Induced Pluripotent Stem Cells.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
P2860
Q26778233-BEC7C7B5-55D3-4BE6-BA41-5BBE8F74FAFDQ28539253-DE658CFC-B7A8-4194-841A-9F994DE05B43Q28543507-BA064962-1F3A-4A81-894D-610DD0B6FB98Q30695533-CBB2A01C-8854-49DB-8D10-00905B54462CQ33355378-3E612A5C-D0D4-412B-9D44-1560E93C5224Q33420319-84BAD9A1-419E-44F5-9E0C-B3CB421B6448Q33506902-E08AA175-AAFD-4D69-AB18-4A6C879CCB95Q33547499-23FA9535-D861-4215-84D7-DF3F2B1816F9Q33948336-AE61AE34-7EB6-4153-9C9E-4881F442D6E5Q34088052-B4D71075-4642-4262-9043-EF97BBCAB818Q34276778-2DDA4DB2-D5AB-428C-AC05-1C6443DA51D7Q34322427-DBC96E09-9738-47B9-A42B-782C2527E0E9Q34638681-4A5B50FE-D4B0-435B-ADCE-65532CC9D878Q35043797-0A58DF32-47D4-4457-B560-37B456B76F99Q35547233-697229D2-31D3-4F77-9AA4-6EB02AFC8D41Q35672627-3F5EAD1B-002B-4BC7-AB1A-CFF8B5652021Q35673856-9EDEA820-DBB3-4BEF-8DDB-8ABDFB62D1B5Q35930139-79F23D5B-75D8-4357-86C4-947012749F90Q36183605-F426FC5E-51D9-4265-878E-147152BE7327Q36314934-698B7FBD-0DC7-49C5-8D43-F94D8E26F3C7Q36375582-2C167969-E16E-4A2E-AF4A-C12F01499AFCQ36485131-BD6E17F5-6957-42EE-96CC-3052135A5F16Q36597457-7E481340-DBB9-4B69-8ABF-D2BA541D773CQ36691274-D46B589A-2C2F-4FF2-959C-F5C4675DAB30Q36873535-3834B7AA-4D5F-4130-901C-75AC62A19360Q37039037-1F8ADD98-6E3C-4FC8-B9CE-B51745565573Q37044440-0D3551F7-208F-496E-A65C-D39D4DD094E1Q37127602-ADF6251C-DA22-417F-B407-AEBB20A5530BQ37250009-02010E6E-C907-4DAA-B7CF-3CF1EE2FCBC7Q37254024-F094732A-F8E1-463D-9A66-DF352FC653EBQ37360785-C255AC8A-A7F7-41E7-B35C-5ED589D4179CQ37426867-08EF09BF-7DE2-4A43-A4DF-732D0C90DAFFQ37948993-87D53B04-D6AC-467F-BA39-BF06D604DAC6Q38003964-FAF6C1E6-5BF8-42A0-925A-E6EFF1EF1930Q38167816-CD8E1DBD-179A-4850-9C03-3C2C90E3C2C0Q38171564-3CB2481B-DAE6-4D72-BD23-6049B7FC02B0Q38542764-173C4CE9-44DC-4104-8188-8995CBDFD127Q38710968-DADF1EFF-F5B8-42AE-B877-6384F91A0959Q38714705-8A5BFB0E-79B4-43F8-B6F4-CDE316A0B394Q38741041-2112902C-9E5F-49C0-94D5-685F65F86D97
P2860
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of emulsifiers on the ...... res of biodegradable polymers.
@ast
Effects of emulsifiers on the ...... res of biodegradable polymers.
@en
type
label
Effects of emulsifiers on the ...... res of biodegradable polymers.
@ast
Effects of emulsifiers on the ...... res of biodegradable polymers.
@en
prefLabel
Effects of emulsifiers on the ...... res of biodegradable polymers.
@ast
Effects of emulsifiers on the ...... res of biodegradable polymers.
@en
P1476
Effects of emulsifiers on the ...... res of biodegradable polymers.
@en
P356
10.1016/S0168-3659(00)00364-3
P407
P577
2001-03-01T00:00:00Z